Your browser doesn't support javascript.
loading
Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report.
Wang, Ruixiao; Qin, Jiayue; Fan, Yafeng; Li, Zhimin; Chen, Chongjian; Su, Wenzhong.
Afiliación
  • Wang R; Annoroad Gene Technology Co., Ltd, Beijing 100176, People's Republic of China.
  • Qin J; Annoroad Gene Technology Co., Ltd, Beijing 100176, People's Republic of China.
  • Fan Y; Department of Respiration Medicine, Shanxi Cancer Hospital, Taiyuan, Shanxi 030013, People's Republic of China.
  • Li Z; Annoroad Gene Technology Co., Ltd, Beijing 100176, People's Republic of China.
  • Chen C; Annoroad Gene Technology Co., Ltd, Beijing 100176, People's Republic of China.
  • Su W; Department of Respiration Medicine, Shanxi Cancer Hospital, Taiyuan, Shanxi 030013, People's Republic of China.
Onco Targets Ther ; 13: 4183-4187, 2020.
Article en En | MEDLINE | ID: mdl-32523354
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Onco Targets Ther Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Onco Targets Ther Año: 2020 Tipo del documento: Article